Icon WebMD Expert Blogs

Cancer Realities

From diagnosis and treatment to remission and survival


The opinions expressed in WebMD User-generated content areas like communities, review, ratings, or blogs are solely those of the User, who may or may not have... Expand

The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatments or uses of drug products that have not been approved by the U.S. Food and Drug Administration. WebMD does not endorse any specific product, service or treatment.

Do not consider WebMD User-generated content as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.


Wednesday, December 12, 2012

Whaddaya Mean, the Docs Aren’t Sure?

By Heather Millar

Confused Doctor

Last week, lots of headlines came out of the San Antonio Breast Cancer Forum. This happens every year, as breast cancer researchers gather in Texas to present their latest research.

Here’s the news flash that caught my eye: A new British study published in The Lancet concludes that breast cancer patients who take Tamoxifen for ten years, rather than the now standard five years, have a better chance of not dying from cancer.

Let me back up for those of you who are not marinated in breast cancer details as I am. Some breast cancers react to the hormone estrogen as if it were candy. For these patients, who have what’s called “estrogen-reactive” cancer, estrogen jazzes their cancer cells. Estrogen makes their cancer grow. So, after they’ve finished with the initial “slash, burn, and poison” of standard cancer treatment, these patients can take a number of drugs that interfere with estrogen. No estrogen means that cancer cells that might remain in the body and want to grow will have one less weapon at their disposal. Some of these drugs block the production of the hormone; others block the body’s ability to use the hormone. Tamoxifen is one of these drugs.

I take Tamoxifen. I’m now in year two of what I thought would be five years on the drug. I’ve moaned about Tamoxifen on this blog before. I guess I should be grateful that I don’t have the panic-attacks, mood swings, and sleep problems that I’ve heard other breast cancer patients suffer with Tamoxifen.

Mostly, Tamoxifen gives me cramps. Every day. Sometimes, the cramps hit my feet. Sometimes they hit the muscles under my chin, or my fingers. Sometimes, it’s my legs. Just try stretching out your chin or your ring finger! Also, Tamoxifen makes it really, really hard to keep your weight down. I haven’t reached zeppelin proportions, but I’m plumper than usual. Watching what I eat and running five days a week seem to have no effect on this. I’m on the brink of just admitting that I won’t be able to wear half the clothes in my closet until I stop taking the drug. Hooray for elastic waistbands.

So you can imagine how thrilled I was to learn that this new study says I should take Tamoxifen for ten years, not five. Will those now-too-small pants even be in fashion by the time I’m off the medication?

But, wait a sec, according to my oncology nurse practitioner, there have been many studies published on the topic of how long patients need to take Tamoxifen to give them the best chance of survival: In 2008, another study concluded than ten years on tamoxifen is better than five. Then, in 2009, another study said maybe seven years was best, echoing data from a 2005 study. Then, in 2010, a review of studies put it back down to five years.

So what’s a patient to do? Obviously, the question of how much tamoxifen is enough tamoxifen remains a subject of debate among oncologists. That’s also true of the value of treating early prostate cancer, or screening for lung cancer, or many other things. One of the hardest lessons of being a cancer patient, I think, is realizing that cancer is just 50 shades of gray. Many times, you reach a point where you have to make a treatment decision and there is no right answer. There is this data, and that data. There is your oncologist’s advice, and your preferences. Then, you just make a choice. No guarantees.

As with many studies, news reports are right to point out that this latest Tamoxifen study shows a benefit measured in a couple of percentage points. Nine years post-diagnosis, 15 percent of the women who took Tamoxifen for five years had died of breast cancer. Of those who’d taken the drug for ten years, 12 percent had died. That’s three percentage points. That’s not nothing. But neither would I say that it’s overwhelmingly conclusive.

So what will I do? I’ll get to five years, and consider whether I can put up with the side effects for a while longer. No doubt, several more studies will have been published by then. I’ll just make my best guess. Hopefully, I’ll be able to live with that.

Photo: Wavebreak Media

Posted by: Heather Millar at 3:02 am


Leave a comment

Subscribe & Stay Informed


Sign up for the Cancer newsletter and keep up with all the latest news, treatments, and research with WebMD.


WebMD Health News